China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

Rondo Therapeutics, a privately held biopharmaceutical immuno-oncology company pioneering the development of next-generation ...

Attorney generals from 22 states have filed a lawsuit against the Trump Administration for slashing funding for medical and ...

My brother always had really bad ear problems,” said Hardiman, 37, who’s based in Seattle, just like her mother was during her 25-year career. On a flight when Hardiman was 11, she remembers flight ...